Skip to main content
Premium Trial:

Request an Annual Quote

Toronto Institute Collaborates with AB Sciex on New Mass Spec Platform

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteomics tools developer AB Sciex said today that it is collaborating with Mount Sinai Hospital's research institute in Toronto to study proteins involved in cancer, diabetes, and heart disease.

Mount Sinai's Samuel Lunenfeld Research Institute is using an emerging mass spectrometry platform that is being developed by AB Sciex to analyze complex protein interactions and modifications in the pathways and processes involved in cellular communication. AB Sciex said that the new platform "combines qualitative and quantitative analysis at high resolution, high speed, and high sensitivity with accurate mass."

The collaboration with the Lunenfeld scientists also will help AB Sciex develop new workflows and applications that will be available when the mass spec platform is launched sometime later this year.

"Through the development of workflows and applications, we will be able to deliver more effective ways of working that will be available on the industry's most unique mass spectrometry platform." AB Sciex VP and GM of Pharmaceuticals and Proteomics Dave Hicks said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.